Evidence map
Motion sickness: what the evidence base looks like
25 publications, 11 of them trials and 8 syntheses. This page describes the shape of that literature rather than summarising its conclusions.
What this literature is made of
This is a well-developed evidence base: multiple syntheses sitting on a substantial body of trials. Questions here are usually about applicability rather than about whether an effect exists.
The distinction that matters most is between synthesis and primary research. A meta-analysis pools trials and is the closest thing to a settled answer a field produces. A narrative review is one group's reading of the same material and can be selective without being dishonest. Counting them together, which most citation counts do, obscures exactly the thing you want to know.
How this page is built
Everything above is computed from the citations this site harvested from PubMed and Crossref, not written by hand. When the weekly harvest finds a new paper on this topic, these counts change and the characterisation changes with them. That is the point: a hand-written claim about how strong an evidence base is starts decaying the day it is written.
Publication type is taken as the source records it. That is imperfect — journals label inconsistently, and a paper indexed as a "review" may be a systematic one — so treat the bands as approximate. They are accurate enough to distinguish a trial literature from a commentary literature, which is the distinction that matters.
The strongest work on this topic
Ordered by study design first, then recency. The full set is listed in the references below.
- Scopolamine for patients with motion sickness: a systematic review and meta-analysis with trial sequential analysis — Zhang YX, Niu XY, Xiao ZY et al., 2024, meta-analysis
- Update on PONV-What is new in prophylaxis and treatment of postoperative nausea and vomiting? : Summary of recent consensus recommendations and Cochrane reviews on prophylaxis and treatment of postoperative nausea and vomiting — Kienbaum P, Schaefer MS, Weibel S et al., 2022, meta-analysis
- Antihistamines for motion sickness — Karrim N, Byrne R, Magula N et al., 2022, systematic review
- Mal de debarquement syndrome: a systematic review — Van Ombergen A, Van Rompaey V, Maes LK et al., 2016, systematic review
- Scopolamine (hyoscine) for preventing and treating motion sickness — Spinks A, Wasiak J, 2011, meta-analysis
- Scopolamine (hyoscine) for preventing and treating motion sickness — Spinks AB, Wasiak J, Villanueva EV et al., 2007, systematic review
- Scopolamine for preventing and treating motion sickness — Spinks AB, Wasiak J, Villanueva EV et al., 2004, systematic review
- Statement on motion sickness — Unattributed, 2003, clinical guideline
- A comparison of virtual reality and verbal imaginal exposure for childhood anxiety disorders — Biggs BK, Whiteside SPH, Knutson M et al., 2025, randomised controlled trial
- Virtual reality application matches the most established treatment for Mal de Debarquement Syndrome: A non-inferiority, randomized, open clinical trial — Schoenmaekers C, De Smet D, Deblieck C et al., 2024, randomised controlled trial
How much research is there on motion sickness?
Does more research mean a stronger conclusion?
How current is this?
Why does this page not tell me the answer?
References
Every citation below links to the original peer-reviewed record on PubMed or via DOI. Nothing here is a substitute for medical advice.
-
Scopolamine for patients with motion sickness: a systematic review and meta-analysis with trial sequential analysis Zhang YX, Niu XY, Xiao ZY, et al. · Acta oto-laryngologica · 2024 · Meta-analysis DOIPubMed 39225593
-
Antihistamines for motion sickness Karrim N, Byrne R, Magula N, et al. · The Cochrane database of systematic reviews · 2022 · Systematic review DOIPubMed 36250781Full text
-
[Update on PONV-What is new in prophylaxis and treatment of postoperative nausea and vomiting? : Summary of recent consensus recommendations and Cochrane reviews on prophylaxis and treatment of postoperative nausea and vomiting] Kienbaum P, Schaefer MS, Weibel S, et al. · Der Anaesthesist · 2022 · Meta-analysis DOIPubMed 34596699
-
Mal de debarquement syndrome: a systematic review Van Ombergen A, Van Rompaey V, Maes LK, et al. · Journal of neurology · 2016 · Systematic review DOIPubMed 26559820Full text
-
Scopolamine (hyoscine) for preventing and treating motion sickness Spinks A, Wasiak J · The Cochrane database of systematic reviews · 2011 · Meta-analysis DOIPubMed 21678338Full text
-
Scopolamine (hyoscine) for preventing and treating motion sickness Spinks AB, Wasiak J, Villanueva EV, et al. · The Cochrane database of systematic reviews · 2007 · Systematic review DOIPubMed 17636710
-
Scopolamine for preventing and treating motion sickness Spinks AB, Wasiak J, Villanueva EV, et al. · The Cochrane database of systematic reviews · 2004 · Systematic review DOIPubMed 15266468
-
Statement on motion sickness Canada communicable disease report = Releve des maladies transmissibles au Canada · 2003 · Clinical guideline PubMed 14655530
-
A comparison of virtual reality and verbal imaginal exposure for childhood anxiety disorders Biggs BK, Whiteside SPH, Knutson M, et al. · Journal of anxiety disorders · 2025 · Randomised controlled trial DOIPubMed 39879857Full text
-
Virtual reality application matches the most established treatment for Mal de Debarquement Syndrome: A non-inferiority, randomized, open clinical trial Schoenmaekers C, De Smet D, Deblieck C, et al. · Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024 · Randomised controlled trial DOIPubMed 38942708Full text
-
Double-blind randomized N-of-1 trial of transcranial alternating current stimulation for mal de débarquement syndrome Cha YH, Gleghorn D, Doudican BC · PloS one · 2022 · Randomised controlled trial DOIPubMed 35120184Full text
-
Double-Blind Sham-Controlled Crossover Trial of Repetitive Transcranial Magnetic Stimulation for Mal de Debarquement Syndrome Cha YH, Deblieck C, Wu AD · Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology · 2016 · Randomised controlled trial DOIPubMed 27176615Full text
-
A comparison of cinnarizine and transdermal scopolamine for the prevention of seasickness in naval crew: a double-blind, randomized, crossover study Gil A, Nachum Z, Tal D, et al. · Clinical neuropharmacology · 2012 · Randomised controlled trial DOIPubMed 22139622
-
Incidence of vomiting in susceptible children under regional analgesia with two different anaesthetic techniques Sarti A, Busoni P, Dell'Oste C, et al. · Paediatric anaesthesia · 2004 · Randomised controlled trial DOIPubMed 14996265
-
Chlorpheniramine for motion sickness Buckey JC, Alvarenga D, Cole B, et al. · Journal of vestibular research : equilibrium & orientation · 2004 · Randomised controlled trial PubMed 15156097
-
A comparison of cyclizine, ondansetron and placebo as prophylaxis against postoperative nausea and vomiting in children O'Brien CM, Titley G, Whitehurst P · Anaesthesia · 2003 · Randomised controlled trial DOIPubMed 12886917
-
Effect of timing of ondansetron administration on incidence of postoperative vomiting in paediatric strabismus surgery Madan R, Perumal T, Subramaniam K, et al. · Anaesthesia and intensive care · 2000 · Randomised controlled trial DOIPubMed 10701032
-
Prophylactic therapy with combined granisetron and dexamethasone for the prevention of post-operative vomiting in children Fujii Y, Saitoh Y, Tanaka H, et al. · European journal of anaesthesiology · 1999 · Randomised controlled trial DOIPubMed 10434165
-
Prevention of postoperative vomiting with granisetron in paediatric patients with and without a history of motion sickness Fujii Y, Saitoh Y, Tanaka H, et al. · Paediatric anaesthesia · 1999 · Randomised controlled trial DOIPubMed 10597557
-
The Neurophysiology and Treatment of Motion Sickness Koch A, Cascorbi I, Westhofen M, et al. · Deutsches Arzteblatt international · 2018 · Review DOIPubMed 30406755Full text